| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Feb 25 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Sell | Dispose S | No | Yes | 8.12 | 20,000 | 162.40 k | 1,273,156 |
| 6 Feb 25 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Conversion | Acquire C | No | No | 0 | 20,000 | 0.00 | 1,293,156 |
| 6 Feb 25 | RXRX Recursion Pharmaceuticals | Class B Common Stock Class A Common Stock | Conversion | Dispose C | No | No | 0 | 20,000 | 0.00 | 5,936,700 |
| 5 Feb 25 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Sell | Dispose S | No | Yes | 7.68 | 20,000 | 153.60 k | 1,273,156 |
| 5 Feb 25 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Conversion | Acquire C | No | No | 0 | 20,000 | 0.00 | 1,293,156 |
| 5 Feb 25 | RXRX Recursion Pharmaceuticals | Class B Common Stock Class A Common Stock | Conversion | Dispose C | No | No | 0 | 20,000 | 0.00 | 5,956,700 |
| 3 Feb 25 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Payment of exercise | Dispose F | No | No | 7.25 | 5,569 | 40.38 k | 1,273,156 |
| 3 Feb 25 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 16,809 | 0.00 | 1,278,725 |
| 3 Feb 25 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 525,283 | 0.00 | 1,261,916 |
| 3 Feb 25 | RXRX Recursion Pharmaceuticals | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 7.25 | 1,050,567 | 7.62 mm | 1,050,567 |
